Press Releases Detail:
Avitar, Inc. and Pinkerton Services Group Commence Strategic Co-Marketing Agreement
January 23, 2001
CANTON, MA – January 22, 2001--Avitar, Inc. (AMEX: AVR) announced today that it has signed a strategic co-marketing agreement with Pinkerton Services Group (PSG) of Charlotte, NC. Pinkerton Services Group will market and distribute Avitar’s ORALscreen™ and HAIRscreen™ drug test product lines in conjunction with its investigation, employee assessment, and substance abuse program services. Under this agreement, Avitar will promote Pinkerton Services Group’s services through its national sales force.
"We are very enthusiastic about pairing our ORALscreen drug testing procedure with Pinkerton Services Group’s comprehensive approach to helping companies with their Drug-Free Workplace Programs," said Peter Phildius, Avitar’s Chairman and Chief Executive Officer.
"Partnering with the industry leader, who for 30 years has delivered workplace security solutions, will provide us with new avenues to communicate the economic and technical value of our oral fluid and hair-based drug testing products. This arrangement will greatly benefit our customers who demand quality solutions that bolster the effectiveness of their employee hiring process and Drug-Free Workplace Programs," Phildius added.
"Pinkerton’s alliance with Avitar supports our efforts to partner with organizations that help to redefine industry standards. Avitar’s dedication to providing consistent, accurate and timely results is in concert with PSG’s philosophy of offering our clients the benefit of quality employee selection and communication programs. We look forward to offering our clients Avitar’s innovative substance abuse testing products," said James M. Powell III, Senior Vice President, Pinkerton Services Group.
ABOUT ORALscreen™
Avitar’s ORALscreen™ is the world’s first oral fluid point-of-collection drugs-of-abuse system for detecting marijuana (THC), cocaine, opiates, methamphetamine and MDMA, also known as Ecstasy. ORALscreen™ is a highly sensitive, yet simple-to-use, reliable portable drug test that detects the presence of specific illegal substances within minutes. ORALscreen™ allows for oral fluid to be collected under readily observable conditions, on-site and on-demand, making it nearly impossible to contaminate test results. This procedure is offered at a low net cost and is used effectively to conduct pre-employment, periodic, and random drug tests.
ABOUT PINKERTON SERVICES GROUP
Pinkerton Services Group (), a division of Pinkerton Consulting & Investigations, provides proven hiring tools and strategies to help ensure that clients hire qualified, honest employees and minimize negligent hiring concerns, reduce turnover, and increase productivity. Pinkerton Services Group is the One Sourcesm clients need for employee selection and communication solutions. Other services offered by Pinkerton Services Group include Recruiting, Stanton® Assessments, Structured Interviews, Esteemsm Information Services, Background Verifications, and compliance-based employee communication programs. Pinkerton Services Group brings unsurpassed resources, personnel and technology together to protect and enhance company’s success.
Founded in 1850 by Allan Pinkerton…The Original Private EyeSM…Pinkerton (www.pinkerton.com) is now a wholly owned subsidiary of Securitas AB of Stockholm, Sweden. The combined companies make up the world’s largest security services provider with more than 210,000 employees worldwide and revenues exceeding $5.5 billion (U.S.).
ABOUT AVITAR, INC.
Avitar, Inc. (AMEX: AVR) headquartered in Canton, Massachusetts, develops, manufactures and markets innovative medical devices based on core technologies in oral fluid diagnostics and customized polyurethane applications. The company markets a unique portfolio of substance abuse testing products and services that include ORALscreenTM, the world’s first rapid point-of-collection oral fluid test for drugs of abuse, ORALadvantage™, the first comprehensive substance abuse program featuring its oral fluid-based products, HAIRscreenTM, a laboratory-based test for detecting long term drug abuse using hair, and several other specialized tests for drugs of abuse. Additional products include an oral fluid collection system for DNA testing as well as a proprietary line of polyurethane-based high tech medical devices.
For more information, see Avitar’s website at avitarinc.com.
This release contains forward looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the company’s filings with the Securities and Exchange Commission.
# # #
|
